Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis

NCT02762500 is registered in ClinicalTrials.gov with Lycera Corp. as lead sponsor.

NCT NCT02762500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02762500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Lead sponsor
Lycera Corp.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
May 31, 2018
Enrollment
124 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative